Bupivicaine Hydrochloride Injection, Solution
Product Images NDC 51662-1456

The use of Bupivacaine Hydrochloride with 0.75% concentration is not recommended for obstetrical anesthesia due to reports of cardiac arrest and death. It is suggested that this concentration be reserved for surgical procedures where muscle relaxation and prolonged effect are necessary. In most cases, there have been difficulties in resuscitation even with adequate preparation and appropriate management. Cardiac arrest has occurred following convulsions resulting from systemic toxicity, presumably from unintentional intravascular injection.*

This is a table showing the concentration of Bupivacaine Hydrochloride and Sodium Chloride in milligrams per milliliter for different solutions of different strengths, ranging from 0.25% to 0.75%.*

This is a table showing the concentration of Bupivacaine HCl, Epinephrine, and Sodium Chloride in different levels of Bupivacaine solutions. The concentrations range from 0.25% to 0.75% and the measurements for Epinephrine and Sodium Chloride are consistent for all the solutions. It is likely related to medical or pharmaceutical use.*

This text describes different pharmaceutical products with varying doses, forms, and packaging. It includes the unit of sale, NDC codes, and other relevant information such as the pH value. The products range from single-dose tear-top vials to multiple-dose flip-top vials, with doses ranging from 25mg to 250mg, and concentrations ranging from 5my/ml to 75mg/mt. The text also indicates that there are 25 units per tray for all the products listed.*

The text provides information about different quantities and packaging options for various medications identified by their NDC codes, strengths, and doses. The medications include teartop vials and fliptop vials in single-dose and multiple-dose options with varying strengths of 25 mg/m, 50 mg/10 mt_, 75 ma/50 mL, 125 mg/50 mL, 150 mg/30 mL, and 250 mg/50 mL. The pH value for all medications is 331055.*

This text contains information related to the different percentages of local anesthetics used for various types of nerve blocks and epidurals. It also mentions the use of test doses for epidurals and the use of dental blocks with a specific concentration of epinephrine.*

This is a list of various drugs that are categorized under different groups including nitrates, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Some examples include nitric oxide, lidocaine, and phenytoin among others.*

This is a description of a pharmaceutical product. The name of the product is not provided. The text contains some codes and numbers that are not clear. The product comes in a single-use teartop vial of 30 mL which is preservative-free. It contains 0.5% Bupivacaine Hydrochloride Injection, USP with a dosage of 150 mg/30 mL (5 mg/mb g). The product is intended to be used for NERVE BLOCK, CAUDAL, and EPIDURAL ANESTHESIA purposes. It is manufactured for Hospira, Inc located in Lake Forest, IL, USA. It comes with a manufacturer's package insert, and it is for RX ONLY use.*

This is a single-use Teartop vial containing 0.5% Bupivacaine Hydrochloride Injection, USP, which is preservative-free. This medication is used for nerve block, caudal, and epidural anesthesia, but not for spinal anesthesia. Each 30 mL vial has a concentration of 150 mg/30 mL (5 mg/mL) with each mL containing 5 mg of bupivacaine HCl, anhydrous and 8.1 mg of sodium chloride. The vial may contain NaOH and/or HCl for pH adjustment. This product is sterile, nonpyrogenic, and the usual dosage and administration route can be found in the insert. It is manufactured in India and made for Hospira, Inc in Lake Forest, IL, USA. The product is available by prescription only and has an NDC code of 0409-1162-19. The vial should be stored at 20 to 25°C (68 to 77°F) per USP Controlled Room Temperature requirements.*

This is a description of a single-use teartop vial that contains 30 mL of preservative-free 0.5% bupivacaine hydrochloride injection USP. It is sterile, nonpyrogenic, and is intended for nerve block, caudal and epidural anesthesia. The vial has an NDC number of 0409-1162-19 and should be stored at controlled room temperature. The vial contains 150 mg/30 mL (5 mg/ml) of bupivacaine hydrochloride and can only be dispensed by prescription (Rx only).*

This is a prescription-only single-dose vial of 30 mL capacity named "Teartop" which contains Bupivacaine Hydrochloride Injection USP. Each milliliter of this preservative-free solution contains 5 mg of anhydrous bupivacaine hydrochloride and 0.5% bupivacaine chloride (8.1mg). The pH of the solution may have been adjusted with NaOH and/or HCl. It can be used for the usual dosage of 150 mg/30 mL (5 mg/mL) for nerve block, caudal, and epidural anesthesia. This solution is sterile, non-pyrogenic, and should be stored within 20 to 25°C (68 to 77°F). It is not meant for spinal anesthesia. This product is distributed by Hospira, Inc., based in Lake Forest, IL, USA.*

This is a description of a medication in a 30 mL single-dose teartop vial. The medication is bupivacaine HCl injection USP, which is used for nerve block, epidural anesthesia, and caudal injection. The vial contains 150mg/30mL, with each mL containing 5mg of anhydrous bupivacaine HCl and 8.1mg of sodium chloride. There are no preservatives, and the medication is sterile and non-pyrogenic. The dosage and route of administration should be determined by a healthcare professional. The medication is not for spinal anesthesia and may contain NaOH and/or HCl for pH adjustment. The vial should be stored at 20 to 25°C (68 to 77°F) and is distributed by Hospira, Inc, Lake Forest, IL 60045 USA. LOT and EXP numbers are provided.*